Поисковый запрос: (<.>S=CENTOCOR<.>) |
Общее количество найденных документов : 12
Показаны документы с 1 по 12
|
1.
| Update on Mabs to treat rheumatoid arthritis // Biotechnol. News, 1995. Vol. 15, N 20.-С.3-4
|
2.
| Centocor reaches profitability in 4Q96 // Phapm. Buss. news, 1997. Vol. 13, N 285.-С.17-18
|
3.
| Centocor prepares to marker CenTNF itself // Phapm. Buss. news, 1997. Vol. 13, N 289.-С.22
|
4.
| Lawsuits over monoclonals to gram-negative bacteria settled // Drug License Opport., 1988. Vol. 14 nov..-С.456-457
|
5.
| Centocor disappoints analysts // Pharm. Bus. news, 1998. Vol. 14, N 308.-С.18
|
6.
| Update on Mabs to treat rheumatoid arthritis // Biotechnol. News, 1995. Vol. 15, N 20.-С.3-4
|
7.
| ReoPro approval, first major milestone in Centocor resurgence // Biotechnol. Newswatch, 1995, N 2jan..-С.4, 5
|
8.
| Angioplasty MAb gets FDA group nod // Biotechnol. Newswatch, 1994, N 20june.-С.2
|
9.
| ReoPro available in U.S. market // Biotechnol. Newswatch, 1995, N 20febr..-С.2
|
10.
| Centocor prepares to marker CenTNF itself // Phapm. Buss. news, 1997. Vol. 13, N 289.-С.22
|
11.
| Centocor prepares to marker CenTNF itself // Phapm. Buss. news, 1997. Vol. 13, N 289.-С.22
|
12.
| Celltech and Centocor Mabs for arthritis likely to move into Phase III trials // Biotechnol. News, 1994. Vol. 14, N 26.-С.1-2
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"